2017-04354. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP15-0020301SUPP17, Supplement to Enhance Laboratory and Statistical Support of the Population Registry of Diabetes in Youth.

TIME AND DATE:

11:00 a.m.-2:00 p.m., EDT, March 29, 2017 (Closed).

PLACE:

Teleconference.

STATUS:

The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

MATTERS FOR DISCUSSION:

The meeting will include the initial review, discussion, and evaluation of applications received in response to “Supplement to Enhance Laboratory and Statistical Support of the Population Registry of Diabetes in Youth”, FOA DP15-0020301SUPP17.

CONTACT PERSON FOR MORE INFORMATION:

Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: [phone], [e-mail] delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.